Documents

A list of downloadable documents created during development.

Alzheimer's disease - donepezil, galantamine, rivastigmine and memantine (review): EIA form for guidance development

Alzheimer's disease - donepezil, galantamine, rivastigmine and memantine (review): final appraisal determination

Alzheimer's disease - donepezil, galantamine, rivastigmine and memantine (review): appraisal consultation

Alzheimer's disease - donepezil, galantamine, rivastigmine and memantine (review): assessment report

Alzheimer's disease (mild to moderate) - donepezil, galantamine, rivastigmine and memantine (part review): final protocol

Alzheimer's disease (mild to moderate) - donepezil, galantamine, rivastigmine and memantine (part review): final matrix

Alzheimer's disease (mild to moderate) - donepezil, galantamine, rivastigmine and memantine (part review): final scope

Alzheimer's disease (mild to moderate) - donepezil, galantamine, rivastigmine and memantine (part review): response to comments on the provisional matrix

Alzheimer's disease (mild to moderate) - donepezil, galantamine, rivastigmine and memantine (part review): response to comments on the draft scope

Alzheimer's disease (mild to moderate) - donepezil, galantamine, rivastigmine and memantine (part review): provisional matrix

Alzheimer's disease (mild to moderate) - donepezil, galantamine, rivastigmine and memantine (part review): draft scope